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ABSTRACT
Background: Multiple studies have been reported regarding preeclampsia as a possible risk 
factor of cerebrovascular disease (CVD). However, the correlation of preeclampsia and CVD, 
whether it is a cause-effect relationship or they are sharing common predisposing condition, 
is not well understood. Therefore, the aim of this study was to investigate the association 
between the preeclampsia during pregnancy and development of postpartum CVD.
Methods: A total of 1,384,550 Korean women who had a delivery between January 1, 2010 and 
December 31, 2012, were enrolled. Women with the risk of CVD within 1 year prior to pregnancy 
were excluded based on the Charlson comorbidity index. Primary endpoint was the event of 
CVD within a year from delivery. After exclusion, 1,075,061 women were analyzed.
Results: During the follow-up of 1 year postpartum, there were 25,577 preeclampsia out 
of 1,072,041 women without postpartum CVD (2.39%), and 121 of 3,020 women with 
postpartum CVD had preeclampsia before delivery (4.01%). In multivariate logistic 
regression analysis, women who had preeclampsia during pregnancy showed a higher risk for 
postpartum CVD (odds ratio, 1.64; 95% confidence interval, 1.37–1.98).
Conclusion: The incidence of CVD after delivery was higher in women who had preeclampsia 
during pregnancy.
Keywords: Cerebrovascular Disease; Pregnancy; Postpartum Period; Preeclampsia;  
Insurance Claim Reporting; Korea
INTRODUCTION
Cerebrovascular disease (CVD) is a leading cause of mortality and morbidity in women, 
accounting for about 50% of total cardiovascular deaths in the United States. Besides, about 
two thirds of survivors developed residual disability. Although women younger than 30 years 
have a stroke incidence less than 5%, the effect of stroke on long-term disability is even 
greater in this age group. According to the American Stroke Association, the risk for stroke is 
higher in pregnant women than in non-pregnant young women, with the highest stroke risk 
occurring in the third trimester and postpartum.1,2 The physiologic changes of pregnancy, 
specifically venous stasis, edema, and hypercoagulability caused by activated protein C 
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resistance, lower levels of protein S, and increase fibrinogen, when combined, increase risk 
for CVD during pregnancy and the postpartum period.3
Preeclampsia is a leading cause of severe maternal morbidity, mortality, and adverse perinatal 
outcomes, which complicates approximately 2%–8% of all pregnancies; it is characterized by 
dysfunctional remodeling of maternal vessels at the implantation site.4 Increased placental 
oxidative stress by shallow invasion of trophoblasts leads to endothelial dysfunction and a 
systemic inflammatory response.5 Many studies have reported that preeclampsia increases 
risks for cardiovascular disease.6-9 Preeclampsia is also one of the common risk factors for 
CVD1,10 and high systolic blood pressure (BP) is the top risk factor for stroke, regardless of 
age or ethnicity.10-12
Moreover, many studies have reported about preconception risk factors of preeclampsia such 
as pre-pregnancy obesity, uncontrolled BP; and maternal diseases including lupus, diabetes 
or thrombocytopenia, and maternal gene polymorphism.13-16 As previously mentioned, 
preeclampsia increases the risk for CVD. However, additional studies are required to 
determine causal relationships between preeclampsia and CVD. It is difficult to distinguish 
whether preeclampsia itself is a risk factor of CVD, as the risk factors of both preeclampsia 
and CVD are similar. Furthermore, although preeclamptic patients recover after delivery or 
termination of pregnancy,5 no evidence has been reported regarding how long the risk for 
CVD after delivery of a preeclamptic pregnancy will be sustained.
Preeclampsia has been reported as one of the risk factors for CVD,17 however, it is unclear 
if preeclampsia causes CVD itself or if a predisposing condition for preeclampsia in the 
pre-pregnancy period also attributes to CVD. It is vitally important to investigate whether 
preeclampsia could be a risk factor of CVD within 12 months after delivery in women without 
risk factors of CVD before pregnancy. Therefore, the aim of this study was to investigate the 
association between the development of postpartum cerebrovascular disease (PCVD) and 
preeclampsia during pregnancy. Additionally, we aimed to evaluate the temporal distribution 
pattern of the incidence of PCVD within 12 months in Korean population.
METHODS
Health care delivery system in Korea
Study data for 2009–2013 were collected from the Korea National Health Insurance (KNHI) 
claims database of the Health Insurance Review and Assessment Service (HIRA). In Korea, 
97% of the population is obligated to enroll in the KNHI program. Healthcare providers are 
required by health insurance policies to allow HIRA to review the medical costs incurred. The 
remaining 3% of the population is covered under the Medical Aid Program. Thus, the HIRA 
database contains information on all claims for approximately 50 million Koreans, and nearly 
all information about the volume of disease can be obtained from this centralized database 
with the exception of procedures not covered by insurance, such as cosmetic operations. 
Many epidemiological analyses have been published from this database. According to the Act 
on the Protection of Personal Information Maintained by Public Agencies, HIRA prepares 
the claims data by concealing individual identities.18 The database we received included an 
unidentifiable code representing each individual together with his/her age, diagnosis, and a 
list of prescribed procedures.
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Study population
Fig. 1 shows the flow chart illustrating the inclusion and exclusion of study participants. The 
International Classification of Diseases, Tenth Revision (ICD-10) diagnostic code was used to 
identify all women who gave birth and women who were diagnosed as having CVD during the 
study period. The current study included only women who had given birth between January 1, 
2010 and December 31, 2012.
Women were classified as having CVD if they were newly diagnosed having CVD (ICD-
10 code, I60–I69) from delivery to 1 year postpartum. The time of each patient's initial 
diagnosis was confirmed by the lack of a medical claim for CVD as a primary or secondary 
disease before delivery from January 1, 2009. To evaluate the effect of pregnancy itself on 
the development of CVD, women who had one or more of the components of the Charlson 
comorbidity index before pregnancy were excluded.19
Data of the women's characteristics such as age, parity, multiple pregnancies (defined as 
twins or higher-order gestation), delivery mode (vaginal delivery or cesarean section), and 
complications of pregnancy (e.g., gestational diabetes mellitus, and preeclampsia), were 
obtained.
Statistical analysis
The Student's t-test was used to compare continuous variables between groups, whereas the 
χ2 test was used to compare categorical variables. A model of multivariate logistic regression 
analysis was performed to evaluate the risk of the development of CVD after delivery. A P value 
< 0.05 was considered statistically significant. Statistical analyses were performed using SPSS 
software, version 12.0 (SPSS Inc., Chicago, IL, USA).
Ethics statement
The present study protocol was reviewed and approved by the Institutional Review Board 
of Yonsei University Medical Center (approval No. 4-2016-1027). No individual informed 
consent was required in this study.
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Deliveries between January 1, 2010
and December 31, 2012 
(n = 1,384,550)
Excluded (n = 82,012)
• Women with CVD before pregnancy
• Women with missing data
Initially included in study cohort
(n = 1,302,538)
Final sample of women available
for analysis
(n = 1,075,061)
Excluded (n = 227,477)
• Women with one or more of the components 
  of Charlson comorbidity index
Fig. 1. Cohort flowchart illustrating the inclusion and exclusion of participants. Women with CVD before 
pregnancy and with missing data were excluded and women with one or more predisposing factors for the CVD 
were excluded. 
CVD = cerebrovascular disease.
RESULTS
Among 1,075,061 women, the prevalence of CVD within 12 months of the postpartum period was 
0.28%. About 2.4% of women without PCVD had preeclampsia during the prenatal period while 
4.0% of women with postpartum CVD had preeclampsia during the prenatal period (P < 0.01).
Basic characteristics of the study population according to the development of CVD within 12 
months of the postpartum period are presented in Table 1. The development of PCVD has 
statistically significant association with old age (more than 35 years, P < 0.01), parity (P < 0.01), 
mode of delivery (P < 0.01), occurrence of preeclampsia (P < 0.01), placental abruption (P < 
0.04), and thromboembolism (P < 0.01) during pregnancy.
Table 2 shows the adjusted odds ratio (OR) for CVD within 12 months of the postpartum period 
according to multivariate logistic regression analysis. The incidence of CVD within 12 months 
of the postpartum period was higher in women with an older age (OR, 1.17; 95% confidence 
interval [CI], 1.07–1.28), cesarean delivery (OR, 1.24; 95% CI, 1.13–1.35), preeclampsia (OR, 
1.64; 95% CI, 1.37–1.98), and thromboembolism (OR, 5.34; 95% CI, 3.30–8.65). Primiparous 
women had a lower incidence of PCVD (OR, 0.79; 95% CI, 0.73–0.85).
The total incidence of CVD for each month of the postpartum period and the incidence of CVD 
in women with preeclampsia during pregnancy are presented in Fig. 2. The incidence of CVD 
within 1 month after delivery was double the rate of that for the other months. Similarly, women 
who had preeclampsia during pregnancy had the highest incidence of CVD within 1 month after 
delivery, and the incidence within 1 month after delivery was approximately three times that of 
the other months.
DISCUSSION
In this study, we found that the incidence of PCVD was increased when the pregnant women 
had preeclampsia during pregnancy. Preeclampsia increased the odds of CVD by 1.7-fold 
in this study, which was relatively lower than the results from other studies reporting an 
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Table 1. Basic characteristics of study population
Parameters Postpartum P value
Normal (n = 1,072,041) CVD (n = 3,020)
Age, yr 30.76 ± 4.10 31.08 ± 4.50 < 0.01
Old age (≥ 35 yr) 179,468 620 < 0.01
Primiparity 563,798 1,406 < 0.01
Multiple pregnancy 15,063 43 0.93
Cesarean delivery 376,427 (35) 1,206 (40) < 0.01
Induction 253,377 669 0.06
Vacuum delivery 66,669 184 0.77
Preeclampsia 25,577 (2.39) 121 (4.01) < 0.01
Gestational diabetes mellitus 20,876 66 0.34
Placenta previa 8,993 23 0.64
Placental abruption 3,973 18 0.04
Peripartum hysterectomy 995 5 0.19
Uterine arterial embolization 890 4 0.35
Postpartum hemorrhage 77,920 208 0.42
Thromboembolism 1,040 17 < 0.01
Values are presented as number (%) or mean ± standard deviation.
CVD = cerebrovascular disease.
increased risk of up to 3.7-fold.7,8,10-15 The reason for relatively lower odds of PCVD in 
this study was attributed to the exclusion of women with a high risk of CVD during the 
preconception period. Nevertheless, it is obvious that preeclampsia independently increased 
the incidence of CVD. Our results support that preeclampsia itself may be an independent 
risk factor for CVD in the postpartum period.
We also found that the patients who had preeclampsia during pregnancy had a higher 
risk of CVD until 12 months after delivery than normotensive women. This means that 
the risk for PCVD might be continuously increased in the postpartum period. Although 
many studies have reported increased risks for PCVD in pregnant women who experienced 
preeclampsia, they were heterogenous between studies in the follow-up period and mean 
age of patients.8,14,16,17,20,21 Most follow-up studies on PCVD after preeclampsia assessed the 
increased risk for PCVD after the follow-up period without continuous assessment during 
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Table 2. Multivariate logistic regression analysis for postpartum CVD
Variables Adjusted OR 95% CI
Old age (≥ 35 yr) 1.17 1.07–1.28
Primiparity 0.79 0.73–0.85
Multiple pregnancy 0.91 0.67–1.24
Cesarean delivery 1.24 1.13–1.35
Induction 1.05 0.95–1.16
Vacuum delivery 1.17 0.99–1.37
Preeclampsia 1.64 1.37–1.98
Gestational diabetes mellitus 1.04 0.82–1.33
Placenta previa 0.76 0.50–1.16
Placental abruption 1.40 0.88–2.23
Peripartum hysterectomy 1.45 0.59–3.58
Uterine arterial embolization 1.41 0.52–3.85
Postpartum hemorrhage 0.93 0.80–1.07
Thromboembolism 5.34 3.30–8.65
CVD = cerebrovascular disease, OR = odds ratio, CI = confidence interval.
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Fig. 2. Incidence of PCVD for each month of the postpartum period. The incidence of PCVD within 1 month after 
delivery was double the rate of that for later months. Similarly, women who had preeclampsia during pregnancy 
had the highest incidence of PCVD within 1 month after delivery, and the incidence within 1 month after delivery 
was approximately three times that of later months. 
PCVD = postpartum cerebrovascular disease.
the period. However, Tang et al.20 reported that preeclampsia/eclampsia increased risk for 
postpartum CVD until 12 months after delivery and they set the interval to examine the risk 
of PCVD as 3 months until 12 months after delivery. In our study, we monitored patients for 
an increased risk of PCVD monthly for 12 months after delivery.
Pregnancy-associated hypertension including preeclampsia is defined as BP that is generally 
normalized 12 weeks after delivery, and patients whose BP becomes normalized do not need 
to be followed up at a hospital.5,22 The task force by the American Congress of Obstetrics 
and Gynecology recommended that health providers should continue BP monitoring 
for postpartum surveillance for 7–10 days after delivery, regardless of hospitalization or 
outpatient follow-up, and it suggested that patients should promptly report signs and 
symptoms of preeclampsia.22 Nevertheless, based on our results, we think that patients 
who had preeclampsia during pregnancy should be instructed to self-monitor their BP at 
least 12 months after delivery. Furthermore, continuous monitoring for PCVD should be 
recommended for at least 12 months after delivery.
In this study, the incidence of CVD was 2.8 per 100,000 deliveries, which is comparable to 
the results from other studies.7,8,11,14,17,23 Interestingly, the incidence of PCVD tended to be 
similar each month, except for the first month after delivery, the rate approximately doubled 
in the first month compared to the average of the other months in both preeclamptic patients 
and non-preeclamptic women. Our results indicate a considerably increasing risk for PCVD 
in pregnant women with and without preeclampsia within 12 months after delivery. As 
previously mentioned, physicians have to follow-up and manage these patients in terms of 
aspects of morbidity because women with CVD in the childbearing period develop long-term 
disability for the rest of their lives.11,24
This pattern of incidence of PCVD can be explained in terms of hemodynamic changes during 
pregnancy and the postpartum period. As previously stated, the exact mechanism for the 
preponderance of stroke during the postpartum period is unknown; hemostatic change leads 
to an increased level of clotting factors and fibrinogen, along with decreased anticoagulation 
and fibrinolytic activity, and a peak level of hypercoagulability is reached around delivery and 
immediately postpartum. Factor VII, fibrinogen, and protein C resistance as well as levels 
of endothelial-derived plasminogen activator inhibitor 1, placenta-derived plasminogen 
activator inhibitor 2, and thrombin activatable fibrinolysis inhibitor increase during 
pregnancy, while anticoagulants, including protein S and the tissue plasminogen activator 
decrease during pregnancy.3,25 These changes gradually return to the nonpregnant state 
around 4 weeks postpartum. Hemostatic changes are probably related to hormonal changes 
during pregnancy to protect against fatal hemorrhage at the time of placental separation.3,25 
Some parameters that reflect endothelial cell damage, including the circulating endothelial 
cell number, soluble vascular cell adhesion molecule-1, and soluble form of vascular 
endothelial growth factor receptor-1, have been reported, and these parameters remain at 
higher levels in pregnant women with preeclampsia than in those without preeclampsia (i.e., 
a normal pregnancy) after delivery.26-28 Additionally, remaining endothelial dysfunction 
could result in microangiopathy in the cerebrovascular system. These previous studies 
supported that preeclampsia increased the risk of PCVD in pregnant women.
In the present study, old age, cesarean delivery, and thromboembolism were associated with 
an increased risk of CVD in the postpartum period. These findings are consistent with those 
of other studies.3,11,29-31
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This study stands out from previous studies with the following reasons. First, the number 
of subjects enrolled was very large. It is difficult to find studies with over 1 million subjects. 
Thanks to national healthcare database with almost every single Korean women's delivery 
records, this cohort minimizes the selection bias. Secondary, this study looked at CVD over 12 
months of postpartum period, in contrary to previous studies only focused on OR of from the 
single moment, even with more 1 million subjects.12,13,32,33 Third, this study offered frequent 
and intense monthly follow-up for the 12 months postpartum. In contrast, other previous 
studies designed for a long-term follow-up only focused on data at 15–40 years after delivery, 
when most of the subjects become postmenopausal women.12,13,21,34 With our study design, 
we found that the risk for the postpartum CVD gets consistently increased until 12 months 
after delivery even with BP being normalized within 12 weeks after birth in preeclampsia 
group. Fourth, the risk of peripartum stroke in preeclamptic/eclamptic pregnancies was 
previously analyzed by Tang et al.20 in Taiwan. The number of subject was very large (n = 
1,132,019), however, this study was limited as the cohort did not exclude the patients who 
already had predisposing risks factors of CVD such as obesity, diabetes mellitus, high 
cholesterol and smoking prior to pregnancy. Moreover, Tang et al.'s study20 compared the 
risks between hemorrhagic and ischemic stroke in preeclampsia, while our study compared 
the risks of postpartum CVD between in the preeclampsia and in the normal pregnancies.
Several limitations of our study should be considered when interpreting our findings. First, 
the diagnosis of preeclampsia was based on insurance claims data from the KNHI claims 
database, which was designed for reimbursement and not for research purposes. Thus, the 
main limitation is the validity of the diagnosis of preeclampsia in this database. However, 
the KNHI claims data, which include the entire Korean population, have greater reliability 
than data from other sources for estimating healthcare utilization in Korea.35 One previous 
validation study comparing the diagnoses derived from the database with the actual diagnosis 
recorded in patients' medical records found that the overall positive predictive value of the 
diagnoses was 83.4% in cases of hospitalized patients.36 Lastly, we are limited in our ability to 
evaluate the association between preeclampsia and PCVD according to the time of onset.
Nevertheless, the strength of the present study was that it used data from a population-
based registry with large numbers. Moreover, we suggested that preeclampsia could be an 
independent risk factor of PCVD after delivery.
In conclusion, higher incidence of CVD within 12 months after delivery is associated with the 
development of preeclampsia during pregnancy.
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